Bicara Therapeutics Inc. (BCAX) Reports Q3 Loss of $0.67
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q3 EPS of ($0.67).
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Corp, Edison Spike; California Assembly Won't Take Vote On Utility Wildfire Bill
- Interactive Brokers (IBKR) call put ratio 1 call 1.2 puts as share price down 6.2%
- Medtronic jumps on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
